Ameriprise Financial Inc Insmed Inc Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Insmed Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 2,530,994 shares of INSM stock, worth $183 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,530,994

Previous 2,735,338 7.47%

Holding current value

$183 Million

Previous $74.2 Million 128.51%

% of portfolio

0.05%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $4.5 Million - $14.2 Million	-204,344 Reduced 7.47%	2,530,994 $170 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $11.6 Million - $13.6 Million	452,847 Added 19.84%	2,735,338 $74.2 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $9.5 Million - $12.9 Million	405,778 Added 21.62%	2,282,491 $70.7 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $347,728 - $471,517	17,509 Added 0.94%	1,876,713 $47.4 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $2.4 Million - $3.07 Million	-145,713 Reduced 7.27%	1,859,204 $39.2 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $16.2 Million - $21.6 Million	-995,384 Reduced 33.18%	2,004,917 $34.2 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $1.6 Million - $2.18 Million	94,095 Added 3.24%	3,000,301 $59.9 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $4.11 Million - $5.56 Million	197,026 Added 7.27%	2,906,206 $62.6 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $13.2 Million - $19.9 Million	-775,049 Reduced 22.24%	2,709,180 $53.4 Million
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $13.8 Million - $19 Million	-674,193 Reduced 16.21%	3,484,229 $81.9 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $290,744 - $375,643	-11,230 Reduced 0.27%	4,158,422 $113 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $2.36 Million - $3.09 Million	104,881 Added 2.58%	4,169,652 $115 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $16.5 Million - $24.6 Million	682,954 Added 20.19%	4,064,771 $116 Million
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $14.2 Million - $19.5 Million	440,220 Added 14.97%	3,381,817 $115 Million
Q4 2020 Feb 12, 2021	BUY	$31.45 - $40.54 $18.4 Million - $23.7 Million	583,995 Added 24.77%	2,941,597 $97.9 Million
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $4.5 Million - $5.97 Million	-173,008 Reduced 6.84%	2,357,602 $75.8 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $6.91 Million - $14.4 Million	489,613 Added 23.99%	2,530,610 $69.7 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $3.34 Million - $8.34 Million	-245,387 Reduced 10.73%	2,040,997 $32.7 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $6.48 Million - $10 Million	401,696 Added 21.31%	2,286,384 $54.6 Million
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $24.8 Million - $41.2 Million	1,598,117 Added 557.67%	1,884,688 $33.2 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $814,867 - $1.14 Million	35,429 Added 14.11%	286,571 $7.34 Million
Q1 2019 May 15, 2019	SELL	$13.91 - $31.15 $2.12 Million - $4.75 Million	-152,487 Reduced 37.78%	251,142 $7.3 Million
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $369,842 - $596,212	31,883 Added 8.58%	403,629 $5.3 Million
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $96,948 - $143,657	5,116 Added 1.4%	371,746 $7.52 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $880,840 - $1.31 Million	44,042 Added 13.65%	366,630 $8.67 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $799,102 - $1.22 Million	36,842 Added 12.89%	322,588 $7.27 Million
Q4 2017 Feb 12, 2018	SELL	$26.43 - $31.78 $337,431 - $405,735	-12,767 Reduced 4.28%	285,746 $8.91 Million
Q3 2017 Nov 07, 2017	BUY	$11.61 - $31.21 $3.47 Million - $9.32 Million	298,513	298,513 $9.32 Million

Others Institutions Holding INSM

# of Institutions

447

Shares Held

170M

Call Options Held

5.79M

Put Options Held

5.18M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.82B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Insmed Inc Transaction History